GEM05
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GEM05, covering 2009-09-18 to 2011-09-19. Get the full timeline:
Most recent: Clinical Trial Update: GEM05 for Patients With Multiple Myeloma More Than 65 Years Old [Phase 3]